Ged Brady
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 15
- Oncology top 5%
- Cancer Cells and Metastasis 10
- Lung Cancer Research Studies 5
- Pancreatic and Hepatic Oncology Research 5
- Molecular Biology top 10%
- Single-cell and spatial transcriptomics 3
- Cell death mechanisms and regulation 3
-
- Lung Cancer Treatments and Mutations 5
- Biomedical Engineering top 10%
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Caroline DiveFiona BlackhallLouise CarterDominic G. RothwellMatthew KrebsRobert MetcalfElaine KilgourCrispin Miller
- Partner nations
- United KingdomGermanyAustralia
In The Last Decade
Ged Brady
31 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 904
- Oncology 969
- Molecular Biology 797
- Pulmonary and Respiratory Medicine 378
- Biomedical Engineering 318
Countries citing papers authored by Ged Brady
This map shows the geographic impact of Ged Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ged Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ged Brady more than expected).
Fields of papers citing papers by Ged Brady
This network shows the impact of papers produced by Ged Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ged Brady. The network helps show where Ged Brady may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ged Brady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 27 | |
| 2 | 2020 | 243 | |
| 3 | 2019 | 4 | |
| 4 | 2019 | 43 | |
| 5 | 2018 | 48 | |
| 6 | 2017 | 33 | |
| 7 | 2017 | 65 | |
| 8 | 2017 | 7 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 239 | |
| 11 | Molecular Characterisation of SCLC Using Both Circulating Tumour DNA and Circulating Tumour Cells Isolated from the Same preserved whole blood sample | 2015 | 1 |
| 12 | 2015 | 18 | |
| 13 | 2015 | 60 | |
| 14 | 2014 | 38 | |
| 15 | Molecular analysis of circulating tumour cells—biology and biomarkersbreakdown → | 2014 | 490 |
| 16 | 2014 | 16 | |
| 17 | 2003 | 83 | |
| 18 | 1998 | 70 | |
| 19 | 1990 | 18 | |
| 20 | 1984 | 5 |
About Ged Brady
Ged Brady is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Cancer Cells and Metastasis (10 papers), Lung Cancer Research Studies (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Lung Cancer Treatments and Mutations (5 papers), Single-cell and spatial transcriptomics (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Cancer Research (904 citations), Oncology (969 citations) and Molecular Biology (797 citations). Ged Brady has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include Caroline Dive, Fiona Blackhall, Louise Carter, Dominic G. Rothwell, Matthew Krebs, Robert Metcalf, Elaine Kilgour, Crispin Miller, Jenny Antonello and Mahmood Ayub. Their work appears in journals such as Molecular Oncology, Blood, Bioinformatics, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.